FMT
IOVA icon

First Mercantile Trust’s Iovance Biotherapeutics IOVA Stock Holding History

First Mercantile Trust’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$137K Sell
5,553
-380
-6% -$8.95K 0.02% 551
2021
Q2 		$154K Buy
+5,933
New +$154K 0.02% 530

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

First Mercantile Trust's IOVA Position: Q3 2021 in Review

First Mercantile Trust reduced its Iovance Biotherapeutics (IOVA) stake by 6.4% in Q3 2021, selling an estimated $8.95K and leaving 5,553 shares worth $137K. The position accounts for 0.02% of the portfolio, ranked #551.

First Mercantile Trust first reported a position in IOVA in Q2 2021 and has held it in 2 quarters since. The position peaked at $154K in Q2 2021. 243 funds tracked by Wall St. Rank hold IOVA as of Q3 2021.

  • First Mercantile Trust held 5,553 shares of Iovance Biotherapeutics worth $137K as of Q3 2021.
  • First Mercantile Trust sold 380 Iovance Biotherapeutics shares in Q3 2021, an estimated $8.95K.
  • Iovance Biotherapeutics made up 0.02% of First Mercantile Trust's portfolio in Q3 2021, its #551 holding.
  • First Mercantile Trust first reported a position in Iovance Biotherapeutics in Q2 2021 and has held it in 2 quarters since.
  • First Mercantile Trust's Iovance Biotherapeutics position peaked at $154K in Q2 2021.
  • 243 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.